The FDA approved on Friday a proposed trial of an insulin infusion set that can be worn for 7 days, according to a press release from Medtronic. An expected longevity of 2 or 3 days is the standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback